Medical breakthroughs – cell and gene therapies
When treatments for disease stop working, cell and gene therapies could be the last chance for survival.
-
Gene therapy
Modification of a person’s genes to cure or significantly improve a disease -
Cell therapy
Replaces or modifies cells within a body to treat a disease
Transforming Lives, Facing New Challenges
Cell and gene therapies are groundbreaking treatments that can potentially cure or dramatically improve serious health conditions. Imagine your employee who, after exhausting traditional options, finds hope in a one-time, life-changing treatment. For many, these therapies offer a second chance at life.
The Cost of Innovation
The high cost and complex adminstration of cell and gene therapies pose unique challenges for health plans and benefit managers trying to balance access, affordability, and risk. Plan sponsors should consider –
- How to manage complex treatments
- Cost management and financial risks
- Outcomes and costs, including value-based agreements
The market for cell and gene therapies is evolving. As new treatments emerge and infrastructure improves, costs and access will change. Staying informed and adaptable is key to managing these innovative therapies effectively.
Should your plan include cell and gene therapies coverage?
Read our POV
Our new POV on “The Rise of Cell and Gene Therapies” explores what strategies employers need to consider when navigating key questions about these treatment options.
Related Solutions